Navigation Links
Zymes LLC, University of Windsor and National Research Council of Canada Collaborative Research Presented at the 2010 Experimental Biology Meeting in Anaheim, California
Date:5/11/2010

HASBROUCK HEIGHTS, N.J., May 11 /PRNewswire/ -- Scientists from Zymes LLC, the University of Windsor (Ontario, Canada) and the National Research Council of Canada presented their research at the 2010 Experimental Biology meetings in Anaheim California on April 28th.  The paper entitled, "Protection of SNpc neurons by water soluble CoQ10 in a paraquat induced rat model of Parkinson's disease: The role of neurotrophic factors," describes a potential treatment for halting the progression of Parkinson's disease in an animal model using Zymes' water soluble CoQ10 (WS-CoQ10) formulation.  

Parkinson's disease (PD) is a neurodegenerative disorder that results from the progressive loss of select neurons in the brain.  Many studies show that mitochondrial dysfunction/oxidative stress is a major contributor to this disease.  An established animal model of paraquat-induced Parkinson's disease was used in this study.  Animals were given Zymes' water soluble CoQ10 in their drinking water with access 24 hours a day pre-treatment (prophylactic) and post-treatment (therapeutic). In these studies, Zymes' water soluble CoQ10 provided significant protection of dopaminergic neurons and a decrease in symptoms.  

"We are very excited about these early stage findings that support the use of Zymes' water soluble CoQ10 to halt the symptoms of Parkinson's disease," said Dr. Shelley Weinstock, Sr. VP of Research and Scientific Affairs.  In addition, in these studies, animals were exposed to the water soluble CoQ10 on a continuous basis in their water, suggesting that small doses, several times a day is a more effective method of administration than larger doses once or twice per day.  More research is needed to determine if Zymes' water soluble CoQ10 may be effective in halting the progression of Parkinson's disease in people.

About Zymes LLC:

Zymes LLC is a bioscience company based in Hasbrouck Heights, NJ that provides innovative solutions to its partners and consumers through proprietary science and technology, enabling new products to enhance the well-being of people. For more information please visit www.zymes.com.


'/>"/>
SOURCE Zymes LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Novozymes Launches Enzyme to Reduce Acrylamide in Food
2. Genencor Appoints New Executive Vice President - Technical Enzymes
3. DOE JGI plumbs termite guts to yield novel enzymes for better biofuel production
4. ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4
5. Novozymes Reports Strong 2008 Results
6. Albemarle Manufactures Zymes PTS, the Lead Compound in a Breakthrough Solubilization Technology
7. Zymes Omega Solutions Bottles and Launches the Worlds First Omega-3 Enhanced Water
8. Human Genome Sciences and Novozymes Announce Amendment to Albumin Fusion License Agreement
9. Reportlinker Adds Industrial Enzymes - A Global Market Report
10. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
11. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today ... (RGC), U.K. Biobank and GSK to generate genetic sequence data ... The initiative will enable researchers to gain valuable insights to ... wide range of serious and life threatening diseases. ... Genetic evidence ...
(Date:3/22/2017)... Denmark , March 22, 2017  Ascendis ... utilizes its innovative TransCon technology to address significant ... financial results for the full year ended December ... significant year for our company as we broadened ... a leading, integrated rare disease company with an ...
(Date:3/22/2017)... 22, 2017 Good Start Genetics, a leading ... the 130 million covered lives mark through its most ... Texas . With newly signed contracts nationally ... enjoy strong payor acceptance based on the quality of ... genetic counseling, its industry-leading customer care and support and ...
(Date:3/22/2017)... LEXINGTON, Mass. , March 22, 2017   ... collections, today announced that Doctors Pathology Service ... mid-Atlantic region of the United States ... the Delaware Health Information Network (DHIN) to ... researchers. The novel program, announced in ...
Breaking Biology Technology:
(Date:3/1/2017)...  Aware, Inc. (NASDAQ: AWRE), a leading supplier of ... Moberg has resigned, effective March 3, 2017, as ... and Treasurer of Aware citing a desire to retire.  ... of the Board of Directors of Aware. ... and co-President, General Counsel has been named Chief Executive ...
(Date:2/26/2017)... 25, 2017  Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring, announces the ... "Too often, too many offenders return ... jails are trying to tackle this ongoing problem ... and family members. While significant steps are underway, Securus ...
(Date:2/16/2017)... 16, 2017  Genos, a community for personal ... has received Laboratory Accreditation from the College of ... to laboratories that meet stringent requirements around quality, ... processes. "Genos is committed to maintaining ... We,re honored to be receiving CAP accreditation," said ...
Breaking Biology News(10 mins):